Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Synvisc® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Synvisc® | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in clinical symptoms | assessed via questionnaire | up to 6 months |
| Amount of medication consumed | up to 6 months | |
| Patient satisfaction on a 4-point verbal rating scale | up to 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with adverse events | up to 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
rheumatological practice
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C049816 | hylan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided